![]() Precision NanoSystems Our proprietary NanoAssemblr™ Platform enables the rapid and controlled manufacture of nanomedicines using microfluidic technology | ![]() Veritas Veritas Intercontinental (formerly known as Veritas Genetics) is a personal genomics company offering a genetic testing platform. | ![]() Xenon Pharmaceuticals XENON® is a biopharmaceutical company focused on the development of novel medicines. | ![]() Regenxbio Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. | ![]() ZIOPHARM Oncology ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer. | |
Founding Date | Founding Date 2010 | Founding Date 2014 | Founding Date 1996 | Founding Date 2009 | Founding Date 2005 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Vancouver, CA HQ South San Francisco, US | Locations Milano, IT HQ Sao Paulo, BR Bogotá, CO Barcelona, ES Madrid, ES | Locations Burnaby, CA HQ | Locations Rockville, US HQ | Locations Boston, US HQ |
Employees | Employees 1055% decrease | Employees 31 | Employees 316 | Employees 4018% increase | Employees 7352% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.2 b | Valuation ($) 447.8 m | Valuation ($) 187.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $5m (Y, 2017) | Revenue (est.) $7.5m (FY, 2025) | Revenue (est.) $170.4m (FY, 2025) | Revenue (est.) $5k (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($345.9m) (FY, 2025) | Net income ($193.9m) (FY, 2025) | Net income ($4.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 13.4m | Total funding raised $ 51.7m | Total funding raised N/A | Total funding raised $ 118.9m | Total funding raised $ 125.1m |

Veritas Intercontinental (formerly known as Veritas Genetics) is a personal genomics company offering a genetic testing platform.
View company
XENON® is a biopharmaceutical company focused on the development of novel medicines.
View company
Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases.
View company
ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.
View company